SEC Form 4 · accession 0001493152-16-008575
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Jay Treat
Officer — Chief Technology Officer
Period of report
Mar 14, 2016
Accepted (ET)
Mar 31, 2016 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.05 | Mar 14, 2016 | A | 54,000 | A | Mar 14, 2016 | Feb 16, 2021 | Common Stock | 54,000 | 54,000 | D |